Plain-English translation of NCT04524416 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a follow-up study for people who already received a MINIject glaucoma implant in a previous trial. Researchers want to track how safe and effective the implant continues to be over five years. You would visit the eye clinic once a year to have your eye pressure measured and your eye health checked.
Glaucoma can cause permanent vision loss if eye pressure gets too high. Many people's eye pressure can't be controlled with eye drops alone, so this implant offers an alternative. This study exists to make sure the treatment is safe and works well over the long term.
If you are already in this study, you will visit the eye clinic once per year for the next three years (continuing from your second year of follow-up to your fifth year). At each visit, doctors will measure your eye pressure, examine your eyes, take images, and check for any problems. The visits are similar to routine eye care appointments.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Colombia
France
Germany